ScoreComparison
Why is CASI Pharmaceuticals, Inc. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate -5.94% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -34.69
2
Negative results in Sep 25
- INTEREST(HY) At USD 0.44 MM has Grown at 278.45%
- NET PROFIT(HY) At USD -24.35 MM has Grown at -31.81%
- RAW MATERIAL COST(Y) Grown by 56.87% (YoY)
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -93.36%, its profits have fallen by -47.1%
4
Below par performance in long term as well as near term
- Along with generating -93.36% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is CASI Pharmaceuticals, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
CASI Pharmaceuticals, Inc.
-93.36%
-0.70
136.88%
S&P 500
14.9%
0.77
19.29%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
18.36%
EBIT Growth (5y)
-5.94%
EBIT to Interest (avg)
-34.69
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.72
Sales to Capital Employed (avg)
-1.41
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
15.21%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.09
EV to EBIT
-0.38
EV to EBITDA
-0.38
EV to Capital Employed
-1.43
EV to Sales
0.61
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
NET PROFIT(HY)
Higher at USD -24.35 MM
ROCE(HY)
Highest at 0%
INVENTORY TURNOVER RATIO(HY)
Highest at 2.22 times
-24What is not working for the Company
INTEREST(HY)
At USD 0.44 MM has Grown at 278.45%
NET PROFIT(HY)
At USD -24.35 MM has Grown at -31.81%
RAW MATERIAL COST(Y)
Grown by 56.87% (YoY
CASH AND EQV(HY)
Lowest at USD 11.45 MM
NET SALES(Q)
Lowest at USD 3.08 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -333.14 %
PRE-TAX PROFIT(Q)
Fallen at -27.34%
Here's what is working for CASI Pharmaceuticals, Inc.
Net Profit
Higher at USD -24.35 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Inventory Turnover Ratio
Highest at 2.22 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Here's what is not working for CASI Pharmaceuticals, Inc.
Interest
At USD 0.44 MM has Grown at 278.45%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Net Sales
At USD 3.08 MM has Fallen at -60.54%
Year on Year (YoY)MOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
Net Profit
At USD -24.35 MM has Grown at -31.81%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Net Sales
Lowest at USD 3.08 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Operating Profit Margin
Lowest at -333.14 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Fallen at -27.34%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Cash and Eqv
Lowest at USD 11.45 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Raw Material Cost
Grown by 56.87% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
